This article is part of the HBOT Radar series, where we summarize the latest published hyperbaric oxygen therapy research.
Fresh Science, Clearly Explained — Brought to you by Brain Spa Hyperbaric
Disclaimer: This article is intended for educational and informational purposes only. It summarizes published medical research conducted in clinical settings and does not evaluate Brain Spa Hyperbaric products. The hyperbaric chambers offered on this website are non-medical wellness devices and are not intended to diagnose, treat, cure, or prevent any disease. Do not make medical decisions based on this article — consult a qualified healthcare professional.
📌 His Sperm Count Was Too Low. 9 Trials Say Oxygen Helped.
🔍 What this review explored
About 15% of couples worldwide struggle with infertility. In roughly half of those cases, the problem is on the male side. And for many men, the diagnosis comes down to the same frustrating set of numbers: not enough sperm (oligospermia), sperm that don't swim well (asthenozoospermia), or sperm with abnormal shapes (teratozoospermia).
Current treatments range from antioxidant supplements to hormone therapy to surgery (especially for varicocele — enlarged veins in the scrotum that overheat the testes). When those don't work, the next step is assisted reproduction — IVF or ICSI — which is effective but expensive, physically demanding for the female partner, and not guaranteed.
What if there was something simpler that could boost sperm quality enough to make a difference — either on its own or alongside existing treatments?
A team from the CITIC-Xiangya Reproductive Hospital in Changsha — one of China's leading fertility centers — gathered every randomized controlled trial ever conducted on hyperbaric oxygen therapy for male infertility. Nine RCTs. Pooled data. One clear picture.
🔬 What the researchers reviewed
This is a systematic review and meta-analysis published in Medical Gas Research, following PRISMA 2020 guidelines and registered with INPLASY. The researchers searched six databases (including three Chinese-language databases) for every RCT comparing HBOT plus standard treatment versus standard treatment alone for male infertility.
Nine RCTs met the inclusion criteria, covering multiple causes of infertility:
- Varicocele (4 studies) — HBOT added to varicocelectomy surgery
- Asthenozoospermia / oligospermia (2 studies) — HBOT added to standard care
- Chronic bacterial prostatitis (1 study) — HBOT added to antibiotics
- Idiopathic male infertility (2 studies) — HBOT added to medication or used with IVF
Treatment durations ranged from 1 to 6 months. Quality was assessed using the Jadad scale.
This study was conducted in a clinical research setting under medical supervision. Results from clinical research cannot be directly applied to other settings or devices — always consult a healthcare professional.
📊 What the evidence shows
Every sperm parameter improved — significantly
The pooled results across all nine trials showed statistically significant improvements in every measured parameter:
- Sperm survival: WMD +22.99 (95% CI: 14.91–31.07, P < 0.01) — substantially more sperm surviving
- Sperm density: WMD +14.90 (95% CI: 11.92–17.88, P < 0.01) — more sperm per milliliter
- Sperm motility: WMD +23.91 (95% CI: 18.53–29.29, P < 0.01) — sperm swimming better
- Normal sperm rate: WMD +15.34 (95% CI: 9.70–20.97, P < 0.01) — more normally shaped sperm
- Sperm abnormality rate: WMD −16.79 (95% CI: −18.31 to −15.28, P < 0.01) — fewer abnormal sperm
That's not one or two parameters improving. That's everything — count, movement, shape, survival — all moving in the right direction, all statistically significant.
And the number that matters most: pregnancy rates went up
Across six studies that tracked pregnancy outcomes, HBOT was associated with a 3.45-fold increase in clinical pregnancy rate (RR = 3.45, 95% CI: 1.38–8.73, P < 0.01).
More sperm, better sperm, and more pregnancies. That's the complete picture.
The cause of infertility matters
Subgroup analysis revealed something clinically useful: HBOT's effectiveness varied by what was causing the infertility.
For varicocele patients (HBOT added after surgical repair), the benefit was strongest for normal sperm morphology — suggesting HBOT helps the testes recover after surgery by improving the local blood supply and oxygen environment.
For asthenozoospermia (low motility), HBOT improved both density and motility with very low heterogeneity — a consistent effect across studies.
The researchers propose that the mechanism is testicular microcirculation: varicocele damages blood flow to the testes, creating a hypoxic (low-oxygen) environment. HBOT directly addresses this by flooding the tissue with oxygen, promoting angiogenesis, and improving the survival conditions for developing sperm.
Longer treatment worked better — and stopping too early caused relapse
An intriguing finding: subgroup analysis showed that treatments lasting 6 months or longer produced better sperm survival rates than shorter courses. And several studies noted a rebound effect — when HBOT was stopped after 3 months, sperm parameters returned toward baseline levels.
The researchers' interpretation: HBOT temporarily improves testicular oxygenation but doesn't fix the underlying cause (e.g., it doesn't repair the varicose veins in varicocele). Sustained treatment may be necessary to maintain benefits.
⚖️ Where the evidence is strong — and where it isn't
What's strong:
- Nine RCTs — this is a meaningful evidence base for a niche topic. All randomized and controlled.
- Consistent results across multiple parameters. Not just one outcome improving — everything improved.
- Pregnancy rates — the ultimate outcome in fertility research. A 3.45x increase is large.
- Mechanistic plausibility — HBOT's effect on microcirculation and tissue oxygenation directly addresses the known pathophysiology of varicocele and other causes of sperm damage.
What deserves caution:
- Most studies are from Chinese populations. Seven of nine trials were conducted in China and published in Chinese-language journals. Regional and ethnic factors may limit generalizability. This is a common pattern in HBOT research — and it means independent replication in Western populations is needed.
- Small individual studies. Most trials had fewer than 100 participants. The pooled numbers are reasonable, but each study alone is underpowered.
- HBOT alone may not be enough. One study found that HBOT alone for idiopathic infertility improved sperm parameters but didn't increase pregnancy rates. The benefit appears to come from combining HBOT with other treatments — surgery, medication, or IVF.
- Publication bias is possible. Studies with positive results are more likely to be published, which could inflate the pooled effect.
- Quality varied. Some studies scored only 2/5 on the Jadad scale (low quality), though most scored 3/5.
📌 Takeaway for the community
- A meta-analysis of 9 RCTs found that adding HBOT to standard infertility treatments significantly improved sperm survival (+23), density (+15), motility (+24), and morphology, with a 3.45x increase in pregnancy rates
- HBOT was effective across different causes of infertility — varicocele, low motility, chronic prostatitis, and idiopathic — but worked best as an add-on to existing treatments, not as a standalone
- Longer treatment courses (6+ months) produced better results, and stopping early may lead to relapse
- Most studies were conducted in Chinese populations — independent replication is needed before widespread adoption
- This study was conducted in a clinical research setting under medical supervision — results cannot be directly applied to other settings or devices
Source: https://pmc.ncbi.nlm.nih.gov/articles/PMC12124701/
Liu B, Wang J, Liu L, Lv M, Zhou D, Li M. Hyperbaric oxygen therapy for male infertility: a systematic review and meta-analysis on improving sperm quality and fertility outcomes. Med Gas Res. 2025;15(4):529-534. doi: 10.4103/mgr.MEDGASRES-D-24-00153.
Educational disclaimer
This content summarizes findings from published medical research for educational purposes only.
The hyperbaric chambers sold on this website are non-medical wellness devices and are not intended to diagnose, treat, cure, or prevent any disease.
The studies discussed here were conducted in clinical medical settings using medical-grade interventions. The inclusion of research summaries does not imply that similar outcomes can be achieved using non-medical wellness devices.
